EUVIMEDEUVIMED entdecken
Open Access

Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR Acinetobacter baumannii

Hanan Al-Lawati, Fatma Al-Raisi, Mahmoud A Elfaky, Mahmoud Saad Abdel-Halim, Hisham A Abbas, Basem Mansour, Wael A H Hegazy, Noura M Seleem

Journal of Microbiology and Biotechnology · 2025

DOI: 10.4014/jmb.2506.06023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Hanan Al-Lawati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Pharmacy Program, Oman College of Health Sciences, Muscat 113, Oman. Hauptthemen laut MEDLINE: Acinetobacter baumannii, beta-Lactamases, Furosemide, Anti-Bacterial Agents. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenems are considered the last line of antibiotic defense against multidrug-resistant (MDR) Acinetobacter baumannii, a bacterium that can secrete carbapenemases such as metallo-β-lactamases (MBLs) to degrade carbapenems. It is thus critical to develop strategies to combat carbapenem resistance, and one of these strategies is to discover MBL inhibitors. In the current study, we evaluated the possible anti-β-lactamase of the approved safe drug furosemide. Furosemide is a loop diuretic with antihypertensive effects. A clinical MDR and carbapenem-resistant A. baumannii isolate was used. Furosemide at 1 mg/ml potentiated meropenem in the combined disk method and interfered with the hydrolytic activities of MBL. Furthermore, furosemide synergized meropenem and decreased its minimum inhibitory concentration (MIC). Furosemide could also reduce the expression of the MBL genes blaNDM and blaVIM. In silico study showed the binding ability of furosemide with the active sites of New Delhi and VIM MBL enzymes, as well as its chelating interaction with zinc ions. Furosemide is a promising MBL inhibitor that can be used in combination with meropenem to treat infections caused by MBL-producing A. baumannii.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniibeta-LactamasesFurosemideAnti-Bacterial Agentsbeta-Lactamase InhibitorsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsMeropenemHumansAcinetobacter InfectionsBacterial ProteinsDrug SynergismCarbapenems

Stichwörter der Autor:innen

Acinetobacter baumanniicarbapenemasesfurosemidemetallo-β-lactamases

Substanzen

beta-LactamasesFurosemideAnti-Bacterial Agentsbeta-Lactamase InhibitorsMeropenemBacterial ProteinsCarbapenems

Autor:innen und Institutionen

  • Department of Pharmaceutics, Pharmacy Program, Oman College of Health Sciences, Muscat 113, Oman.
  • Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Centre for Artificial Intelligence in Precision Medicines, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Microbiology and Immunology Department, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Kut, Kut, Wasit, 52001, Iraq.

Förderung

  • Ministry of Higher Education

Zitieren

APA

Al-Lawati, H., Al-Raisi, F., Elfaky, M. A., Abdel-Halim, M. S., Abbas, H. A., Mansour, B., Hegazy, W. A. H., & Seleem, N. M. (2025). Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR Acinetobacter baumannii. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2506.06023

Vancouver

Al-Lawati H, Al-Raisi F, Elfaky MA, Abdel-Halim MS, Abbas HA, Mansour B, et al. Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR Acinetobacter baumannii. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2506.06023

BibTeX
@article{AlLawati2025,
  author = {Al-Lawati, Hanan and Al-Raisi, Fatma and Elfaky, Mahmoud A and Abdel-Halim, Mahmoud Saad and Abbas, Hisham A and Mansour, Basem and Hegazy, Wael A H and Seleem, Noura M},
  title = {Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR Acinetobacter baumannii},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2025},
  doi = {10.4014/jmb.2506.06023}
}
Kostenlos starten →